Autor: |
Ilona Mossbrugger, Frauke Neff, Ilka Wittig, Evelyn Schiller, Wolfgang Wurst, Valentina Strecker, Andreas Bender, Anja Schrewe, Thomas Floss, Sabine M. Hölter, Valerie Gailus-Durner, Helmut Fuchs, Julia Calzada-Wack, Thomas Meitinger, Thomas Klopstock, Raffi Bekeredjian, Martin Hrabě de Angelis, Michaela Aichler, Tina Wenz, Holger Prokisch, Ramona Zeh, Lore Becker, Dirk Janik, Iulia Dumitru, Leticia Quintanilla-Fend, Eva Kling, Axel Walch |
Jazyk: |
angličtina |
Rok vydání: |
2014 |
Předmět: |
|
Zdroj: |
PLOS ONE PLoS ONE, Vol 9, Iss 12, p e114918 (2014) PLOS ONE 9(12), e114918 (2014). doi:10.1371/journal.pone.0114918 PLoS ONE PLoS ONE 9:e114918 (2014) |
DOI: |
10.1371/journal.pone.0114918 |
Popis: |
Recently, mutations in the mitochondrial translation optimization factor 1 gene (MTO1) were identified as causative in children with hypertrophic cardiomyopathy, lactic acidosis and respiratory chain defect. Here, we describe an MTO1-deficient mouse model generated by gene trap mutagenesis that mirrors the human phenotype remarkably well. As in patients, the most prominent signs and symptoms were cardiovascular and included bradycardia and cardiomyopathy. In addition, the mutant mice showed a marked worsening of arrhythmias during induction and reversal of anaesthesia. The detailed morphological and biochemical workup of murine hearts indicated that the myocardial damage was due to complex I deficiency and mitochondrial dysfunction. In contrast, neurological examination was largely normal in Mto1-deficient mice. A translational consequence of this mouse model may be to caution against anaesthesia-related cardiac arrhythmias which may be fatal in patients. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|